Vitafusion Omega-3 Gummies Interactions
There are 76 drugs known to interact with Vitafusion Omega-3 Gummies (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 76 are moderate.
- View all 76 medications that may interact with Vitafusion Omega-3 Gummies
- View Vitafusion Omega-3 Gummies disease interactions (2)
Most frequently checked interactions
View interaction reports for Vitafusion Omega-3 Gummies (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- Actemra (tocilizumab)
- Advair Diskus (fluticasone / salmeterol)
- Advil (ibuprofen)
- albuterol
- Allegra (fexofenadine)
- amlodipine
- apple cider vinegar
- atenolol
- Ativan (lorazepam)
- atorvastatin
- azithromycin
- Azithromycin Dose Pack (azithromycin)
- B Complex 100 (multivitamin)
- Benadryl (diphenhydramine)
- benzonatate
- Calcium 600 D (calcium / vitamin d)
- Claritin (loratadine)
- Coricidin HBP Day & Night Multi-Symptom Cold (acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin)
- cranberry
- cyclobenzaprine
- Cymbalta (duloxetine)
- hydroxyzine
- ibuprofen
- prednisone
- Vitafusion Women's Gummy (multivitamin with minerals)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Vitafusion Omega-3 Gummies disease interactions
There are 2 disease interactions with Vitafusion Omega-3 Gummies (omega-3 polyunsaturated fatty acids) which include:
Report options
QR code containing a link to this page
More about Vitafusion Omega-3 Gummies (omega-3 polyunsaturated fatty acids)
- Vitafusion Omega-3 Gummies consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.